APPlife Digital Solutions (ALDS) 10-Q 11 May 23 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Mar. 31, 2023	May 11, 2023
Details
Registrant CIK	0001755101
Fiscal Year End	--06-30
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	000-54524
Entity Registrant Name	APPLIFE DIGITAL SOLUTIONS, INC.
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	30-0678378
Entity Address, Address Line One	50 California St
Entity Address, Address Line Two	#1500
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94111
City Area Code	415
Local Phone Number	439 5260
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		150,543,635
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Jun. 30, 2022
Current assets
Cash	$ 57,244	$ 189,233
Prepaid expenses	12,820	8,038
Inventories	80,041	64,200
Total assets	150,105	261,471
Current liabilities
Accounts payable and accrued expenses	105,899	103,355
Common stock payable	10,475	10,475
Notes payable to shareholders	155,053	289,319
Derivative liabilities	770,303	577,180
Due to officer	1,000	0
Total current liabilities	1,042,730	980,329
Notes payable to shareholders - noncurrent, net	190,076	100,000
Total liabilities	1,232,806	1,080,329
Stockholders' deficit
Common stock, $0.001 par value, 500,000,000 shares authorized; 150,043,635 and 148,543,635 shares issued and outstanding as of March 31, 2023 and June 30, 2022	150,045	148,545
Additional paid-in capital	14,527,318	12,410,428
Accumulated (deficit)	(15,760,064)	(13,377,831)
Total stockholders' deficit	(1,082,701)	(818,858)
Total liabilities and stockholders' deficit	$ 150,105	$ 261,471

Consolidated Balance Sheets - P

Consolidated Balance Sheets - Parenthetical - $ / shares	Mar. 31, 2023	Jun. 30, 2022
Consolidated Balance Sheets
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares, Issued	150,043,635	148,543,635
Common Stock, Shares, Outstanding	150,043,635	148,543,635

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Consolidated Statements of Operations
Revenue	$ 12,335	$ 8,475	$ 43,374	$ 10,346
Cost of goods sold	(9,635)	(5,434)	(35,531)	(6,864)
Gross profit	2,700	3,041	7,843	3,482
Operating expenses	778,425	764,429	2,252,802	2,288,026
Total operating expenses	778,425	764,429	2,252,802	2,288,026
Loss from operations	(775,725)	(761,388)	(2,244,959)	(2,284,544)
Other income (expense)
Interest expense	(148,812)	(149,494)	(479,187)	(323,789)
Gain on settlement of debt	0	0	0	48,619
Change in fair value of Common Stock	0	0	0	(11,283)
Change in fair value of derivative liability	91,241	616	341,913	25,139
Net loss before provision for income taxes	(833,296)	(910,266)	(2,382,233)	(2,545,858)
Provision for income taxes	0	0	0	0
Net loss	$ (833,296)	$ (910,266)	$ (2,382,233)	$ (2,545,858)
Basic and diluted loss per share	$ (0.02)	$ (0.02)	$ (0.04)	$ (0.05)
Average number of common shares outstanding - basic and diluted	53,576,511	50,854,024	53,240,148	50,411,115

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Deficit - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings	Total
Equity, Attributable to Parent, Beginning Balance at Jun. 30, 2021	$ 135,526	$ 8,350,779	$ (9,836,731)	$ (1,350,426)
Shares, Outstanding, Beginning Balance at Jun. 30, 2021	135,524,617
Common stock issued for cash, Value	$ 5,200	514,800	0	520,000
Common stock issued for cash, Shares	5,200,000
Stock compensation expense	$ (4,000)	(1,427,758)	0	(1,431,758)
Common stock issued for services, Value	$ 3,819	140,322	0	144,141
Common stock issued for services, Shares	3,819,018
Net loss	$ 0	0	(2,545,858)	(2,545,858)
Equity, Attributable to Parent, Ending Balance at Mar. 31, 2022	$ 148,545	10,433,659	(12,382,589)	(1,800,385)
Shares, Outstanding, Ending Balance at Mar. 31, 2022	148,543,635
Stock compensation expense	$ 4,000	1,427,758	0	1,431,758
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture	4,000,000
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2021	$ 146,647	9,904,132	(11,472,323)	(1,421,544)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021	146,645,612
Stock compensation expense	$ 0	(491,567)	0	(491,567)
Common stock issued for services, Value	$ 1,898	37,960	0	39,858
Common stock issued for services, Shares	1,898,023
Net loss	$ 0	0	(910,266)	(910,266)
Equity, Attributable to Parent, Ending Balance at Mar. 31, 2022	$ 148,545	10,433,659	(12,382,589)	(1,800,385)
Shares, Outstanding, Ending Balance at Mar. 31, 2022	148,543,635
Stock compensation expense	$ 0	491,567	0	491,567
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture	0
Equity, Attributable to Parent, Beginning Balance at Jun. 30, 2022	$ 148,545	12,410,428	(13,377,831)	(818,858)
Shares, Outstanding, Beginning Balance at Jun. 30, 2022	148,543,635
Common stock issued for cash, Value	$ 1,500	16,800	0	18,300
Common stock issued for cash, Shares	1,500,000
Stock compensation expense	$ 0	(1,664,046)	0	(1,664,046)
Net loss	0	0	(2,382,233)	(2,382,233)
Equity, Attributable to Parent, Ending Balance at Mar. 31, 2023	$ 150,045	14,527,318	(15,760,064)	(1,082,701)
Shares, Outstanding, Ending Balance at Mar. 31, 2023	150,043,635
Stock compensation expense	$ 0	1,664,046	0	1,664,046
Settlement of notes payable with issuance of options to purchase common stock	0	436,044	0	436,044
Equity, Attributable to Parent, Beginning Balance at Dec. 31, 2022	$ 148,545	13,923,581	(14,926,768)	(854,642)
Shares, Outstanding, Beginning Balance at Dec. 31, 2022	148,543,635
Stock compensation expense	$ 0	(586,937)	0	(586,937)
Common stock issued for services, Value	$ 1,500	16,800	0	18,300
Common stock issued for services, Shares	1,500,000
Net loss	$ 0	0	(833,296)	(833,296)
Equity, Attributable to Parent, Ending Balance at Mar. 31, 2023	$ 150,045	14,527,318	(15,760,064)	(1,082,701)
Shares, Outstanding, Ending Balance at Mar. 31, 2023	150,043,635
Stock compensation expense	$ 0	$ 586,937	$ 0	$ 586,937
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture	0

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (2,382,233)	$ (2,545,858)
Adjustment to reconcile change in net loss to net cash used in operating activities
Amortization	315,811	122,913
Interest expense	35,336	68,729
Issuance of common stock for services	18,300	144,141
Stock compensation expense	1,664,046	1,431,758
Change in fair value of derivative liability	(341,913)	(25,139)
Gain on settlement of debt	0	(48,619)
Changes in operating assets and liabilities
Prepaid expenses and other current assets	(4,782)	21,332
Inventories	(15,841)	(17,515)
Common stock payable	0	125,616
Accounts payable and accrued expenses	133,287	65,500
Net Cash Provided by (Used in) Operating Activities	(577,989)	(657,142)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable to shareholders	445,000	100,000
Proceeds from issuance of common stock	0	520,000
Payment on notes payable	0	(40,000)
Proceeds from amounts due to officer	1,000	0
Payment on amounts due to officer	0	(5,000)
Net cash provided from financing activities	446,000	575,000
Net decrease in cash and cash equivalents	(131,989)	(82,142)
Cash and cash equivalents, beginning of period	189,233	250,073
Cash and cash equivalents, end of period	57,244	265,407
Non-cash investing and financing activities
Increase in derivative liability upon issuance of convertible note	479,700	168,729
Payment of notes payable with issuance of options to purchase common stock	$ 436,044	$ 0

Note 1 - Organization and Summa

Note 1 - Organization and Summary of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2023
Notes
Note 1 - Organization and Summary of Significant Accounting Policies	Note 1 – Organization, Going Concern and Summary of Significant Accounting Policies Organization APPlife Digital Solutions Inc. (the “Company”) is a business incubator and portfolio manager that uses digital technology to create and invest in e-commerce and cloud-based solutions. The Company was formed March 5, 2018 in Nevada and has offices in San Francisco, California and Shanghai, China. Our office in San Francisco, California allows us to take advantage of the marketing opportunities available in the United States as well as keeping close proximity to sources of capital whether it is debt or equity. Our offices in Shanghai, China allows us to take advantage of a high concentration of skilled tech coders and developers at lower capital costs than in more developed countries such as the United States or Europe. Rooster Essentials APP SPV, LLC (the “Rooster”), incorporated on April 9, 2019, is a wholly owned subsidiary of the Company. Rooster is a fully customizable men’s ecommerce platform that delivers daily use grooming needs and essential items. B2BCHX SPV LLC (the “B2BCHX”), incorporated on June 5, 2019, is a wholly owned subsidiary of the Company. B2BCHX does an independent background check on mainland Chinese companies for small businesses globally. Office Hop, incorporated on January 28, 2021, is a wholly owned subsidiary of the Company. Office Hop is a global sharing model platform for short term rentals of office and meeting rooms. Users can find an office or conference space for hourly, half-day, full-day, or weekly rental. Hosts can list their spare office or meeting rooms. Going Concern The Company has generated losses and negative cash flows from operations since inception. The Company has historically financed its operations from equity financing. The Company anticipates additional equity financings to fund operations in the future. Should management fail to adequately address the issue, the Company may have to reduce its business activities or curtail its operations. There can be no assurance that any additional financings, would be available to the Company on satisfactory terms and conditions if at all. The current pandemic known as COVID-19 as described in Note 5, creates additional uncertainty. The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and classification of liabilities and commitments in the normal course of business. The accompanying unaudited condensed consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classifications of liabilities that might result if the Company is unable to continue as a going concern. Basis of Presentation The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for the interim financial information and with instructions to Form 10-Q and Article 10 of Regulation S-X. The unaudited condensed consolidated financial statements include the accounts of all subsidiaries in which the Company holds a controlling financial interest as of the financial statement date. All intercompany transactions have been eliminated in consolidation. However, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended June 30, 2022, as filed with the SEC on October 7, 2022. Operating results for the nine months ended March 31, 2023 are not necessarily indicative of the results that may be expected for any subsequent quarter or for the fiscal year ending June 30, 2023. Cash and Cash Equivalents For the purpose of the statement of cash flows, the Company considers cash equivalents to include cash and investments with an original maturity of three months or less. Income Taxes The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume that the tax position will be examined by taxing authorities. The Company’s policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. The Company had no accrual for interest or penalties as of March 31, 2023. The Company files income tax returns with the Internal Revenue Service (“IRS”) and the state of California. Use of Estimates Generally accepted accounting principles require that the consolidated financial statements include estimates by management in the valuation of certain assets and liabilities. Significant matters requiring the use of estimates and assumptions include, but are not necessarily limited to, fair value of the Company’s stock, stock-based compensation, BCF (Beneficial Conversion Feature) liabilities feature of convertible debt, and valuation allowance relating to the Company’s deferred tax assets. Management uses its historical records and knowledge of its business in making these estimates. Management believes that its estimates and assumptions are reasonable, based on information that is available at the time they are made. Accordingly, actual results could differ from those estimates. Revenue Recognition The Company will recognize revenue from the sale of products and services in accordance with ASC 606, “Revenue from Contracts with Customers”, Stock Based Compensation The Company accounts for share-based compensation in accordance with the fair value recognition provision of FASB ASC 718, Compensation – Stock Compensation (“ASC 718”), prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on the estimated grant date fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505, Equity–based Payments to Non-Employees (“ASC 505”). Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date. Net Loss per Share Basic net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period, increased by potentially dilutive common shares (“dilutive securities”) that were outstanding during the period. Dilutive securities include stock options and warrants granted, convertible debt, and convertible preferred stock. Restricted shares issued are not included in the calculation of the weighted-average number of common shares outstanding. There were 30,499,099 and 5,094,959 potentially dilutive securities for the nine months ended March 31, 2023 and year ended June 30, 2022, respectively. Fair Value of Financial Instruments The Company follows FASB ASC 820, Fair Value Measurements and Disclosures Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts reported in the Company’s consolidated financial statements for cash, accounts payable and accrued expenses approximate their fair value because of the immediate or short-term nature of these consolidated financial instruments. Derivative Liability FASB ASC 815, Derivatives and Hedging requires all derivatives to be recorded on the consolidated balance sheet at fair value. As of March 31, 2023, we used the Black-Scholes-Merton (BSM) model to estimate the fair value of the conversion feature of the convertible note. Key assumptions of the BSM model include the market price of our stock, the conversion price of the debt, applicable volatility rates, risk-free interest rates and the instrument’s remaining term. These assumptions require significant management judgment. In addition, changes in any of these variables during a period can result in material changes in the fair value (and resultant gains or losses) of this derivative instrument. Inventories Inventory, consisting of raw materials, work in process and products available for sale, are primarily accounted for using the first-in, first-out method (“FIFO”), and are valued at the lower of cost or net realizable value. This valuation requires management to make judgements based on currently available information, about the likely method of disposition, such as through sales to individual customers and returns to product vendors. As of March 31, 2023, the Company had inventories of approximately $80,041. The Company has no allowance for inventory reserves.

Note 2 - Notes payable to stock

Note 2 - Notes payable to stockholders	9 Months Ended
	Mar. 31, 2023
Notes
Note 2 - Notes payable to stockholders	Note 2 – Notes payable to stockholders On January 12, 2021, the Company sold convertible notes bearing 12% interest on the principal amount of $360,000, respectively. The principal amount was agreed to be paid in two tranches of $180,000 each, received on February 19, 2021 and March 08, 2021. The note is subject to certain ownership limitations and will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion rate of $0.144. The embedded conversion features of this note were valued at $35,500 and $7,500 for each tranche received and are amortized over the life of the note. On December 13, 2022, the Company converted the notes, in which on that date, the outstanding $360,000 in principle and $76,044 in interest were converted into 2,952,548 fully vested options to purchase common stock. On February 04, 2022, the Company sold convertible note bearing 12% interest in the principal amount of $350,000 (“February 2022 Notes”). The note will be paid in three tranches with first tranche of $100,000 received on March 28, 2022. The second and third tranches of $150,000 and $100,000 each, were received on May 3, 2022, and June 21, 2022, respectively. The note is subject to certain ownership limitations and will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion rate of $0.013. The February 2022 Notes contain embedded derivatives, see Note 7. On June 8, 2022, the Company converted the July 2019 Notes, November 2019 Note and the 2020 Notes (collectively “Converted Notes”), with an aggregate principal balance of $1,108,000 and $282,838 of accrued interest into stock options. The options expire in five years with the exercise prices ranging between $0.14 and $0.34. The options were valued at $216,981, in the aggregate, using Black Scholes. On August 26, 2022, the Company sold convertible note bearing 12% interest in the principal amount of $325,000 (“August 2022 Notes”). The note is disbursed in three tranches with first tranche of $125,000 received on September 1, 2022. The second tranche of $100,000 was received on September 19, 2022 and the third tranche of $100,000 was received on October 15, 2022. The note is subject to certain ownership limitations and will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion rate of $0.046. The August 2022 Notes contain embedded derivatives, see Note 7. On December 21, 2022, the Company sold convertible note bearing 12% interest in the principal amount of $120,000 (“December 2022 Notes”). The note is disbursed in four tranches with first tranche of $40,000 issued on January 10, 2023, and the remaining tranches of $20,000, $20,000 and $40,000, respectively, to be issued between February 2023 and March 2023. Amount Balance of notes payable, net of discount on June 30, 2022 $ 389,319 Amortization of debt discount 315,810 New Issuances 445,000 Embedded Conversion Feature - Debt discount (445,000) Conversion of Notes Payable less Accrued Interest to stock options (360,000) Balance of notes payable, net of discount as of March 31, 2023 $ 345,129

Note 3 - Related Party Transact

Note 3 - Related Party Transactions	9 Months Ended
	Mar. 31, 2023
Notes
Note 3 - Related Party Transactions	Note 3 – Related Party Transactions Notes Payable to Stockholder During the nine months ended March 31, 2023, the Company received $445,000 in notes payable to related parties which are composed of two notes: (1) $325,000 note and (2) $120,000 note. The first note is disbursed in three tranches with first tranche of $125,000 received on September 1, 2022. The second and third tranches of $100,000 were received on September 19, 2022 and October 15, 2022, respectively. On December 13, 2022, the Company converted notes into fully vested options to purchase common stock. The second note is disbursed in four tranches with the first tranche of $40,000 received on January 10, 2023, second tranche of $20,000 received on February 10, 2023, third tranche of $20,000 received on March 3, 2023 and fourth tranche of $40,000 received on March 31, 2023. See Note 2, Notes Payable to Shareholders, for detail.

Note 4 - Concentrations

Note 4 - Concentrations	9 Months Ended
	Mar. 31, 2023
Notes
Note 4 - Concentrations	Note 4 – Concentrations Cash Concentration The Company maintains its cash and cash equivalents at a financial institution which may, at times, exceed federally insured limits. As of March 31, 2023, the Company’s cash balance did not exceed the FDIC insurance limit.

Note 5 - Commitments and Contin

Note 5 - Commitments and Contingencies	9 Months Ended
	Mar. 31, 2023
Notes
Note 5 - Commitments and Contingencies	Note 5 – Commitments and Contingencies Legal Matters From time to time the Company may be involved in certain legal actions and claims arising in the ordinary course of business. The Company was not a party to any specific legal actions or claims at March 31, 2023. Other Risks There have been outbreaks in several countries, including the United States, of the highly transmissible and pathogenic coronavirus (“COVID-19”). The outbreak of such COVID-19 resulted in a widespread health crisis that adversely affected general commercial activity and the economies and financial markets of many countries, including the United States. Although to date, the Company has not been adversely affected by COVID-19, the measures taken by the governments of countries affected could adversely affect the Company’s business, financial condition, and results of operations.

Note 6 - Stockholders' Equity (

Note 6 - Stockholders' Equity (Deficit)	9 Months Ended
	Mar. 31, 2023
Notes
Note 6 - Stockholders' Equity (Deficit)	Note 6 – Stockholders’ Deficit As of March 31, 2023, and June 30, 2022, there were 150,043,635 and 148,543,635 shares of common stock issued and outstanding, respectively. On July 6, 2021, the Company entered into multiple subscription agreements with investors and issued 5,200,000 shares of common stock, priced at $0.10 per share, for an aggregate purchase price of $520,000. Common stock issued for services During the three and nine months ended March 31, 2023, the Company issued 1,500,000 shares of common stock for services valued at $18,300 with price at $0.0122 per share. During the three and nine months ended March 31, 2022, the Company issued 3,819,018 shares of common stock to third parties for services valued at $144,141 with prices at $0.0495 - $0.08 per share. Restricted stock and stock options During the three and nine months ended March 31, 2023, the Company recognized stock compensation expense on outstanding restricted stock awards of $558,714 and $1,431,722, respectively. During the three and nine months ended March 31, 2022, the Company recognized stock compensation expense on outstanding restricted stock awards of $427,557 and $1,262,058, respectively. During the three and nine months ended March 31, 2023, the Company recognized $28,223 and $232,324 of expense related to the vesting of stock options to its board members and consultants. During the three and nine months ended March 31, 2022, the Company recognized $64,010 and $169,700 of expense related to the vesting of stock options to its board members and consultants. Stock compensation expense is summarized as follows: Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended March 31, 2023 March 31, 2022 March 31, 2023 March 31, 2022 Restricted stock awards $ 558,714 $ 427,557 $ 1,431,722 $ 1,262,058 Stock options awards 28,223 64,010 232,324 169,700 Stock compensation expense $ 586,937 $ 491,567 $ 1,664,046 $ 1,431,758 The options granted in fiscal year 2022 vest pro-rata over the member’s term, have exercise prices between $0.02 and $0.03 and expire in five years from the date of grant. On June 8, 2022, the Company converted a total of $1,309,838 in outstanding notes payable and interest into 8,106,723 options to purchase common stock. On December 13, 2022, the Company converted a total of $436,044 in outstanding notes payable and interest into 2,952,548 options to purchase common stock (see Note 2). Options Weighted Average Exercise Price per Share Weighted Average Remaining Life (Years) Outstanding – June 30, 2022 23,502,035 $ 0.11 2.92 Granted 6,997,064 0.03 4.69 Forfeited - - - Exercised - - - Outstanding – March 31, 2023 30,499,099 $ 0.05 4.25 In connection with the options the Company and valued with Black Scholes using the following inputs: Nine Months Ended March 31, 2023 Stock price $ 0.02 - 0.03 Exercise price $ 0.02 - 0.34 Expected term (in years) 4.94 – 5.00 Volatility (annual) 195.1 % - 380.5 % Risk-free rate 2.42 % - 4.22%

Note 7 - Derivative Liability

Note 7 - Derivative Liability	9 Months Ended
	Mar. 31, 2023
Notes
Note 7 - Derivative Liability	Note 7 – Derivative Liability The Company issued debts that consist of the issuance of convertible notes with variable conversion provisions. The conversion terms of the convertible notes are variable based on certain factors, such as the future price of the Company’s common stock. The number of shares of common stock issuable upon conversion of the promissory note is indeterminate. Pursuant to ASC 815-15 Embedded Derivatives, the fair values of the variable conversion option and shares to be issued were recorded as derivative liabilities on the issuance date and revalued at each reporting period. A summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company’s common stock purchase warrants that are categorized within Level 3 of the fair value hierarchy for the Nine Months Ended March 31, 2023 is as follows: Nine Months Ended March 31, 2023 Stock price $ 0.02 – 0.05 Exercise price $ 0.02 – 0.03 Contractual term (in years) 0.74 – 2.00 Volatility (annual) 213% - 381% Risk-free rate 3.51% – 4.45% The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management’s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuations. Financial Liabilities Measured at Fair Value on a Recurring Basis Financial liabilities measured at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Derivative liability – warrants and derivative liabilities: Fair value measured at March 31, 2023 Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) March 31, 2023 Derivative liability $ - $ - $ 770,303 $ 770,303 Total $ - $ - $ 770,303 $ 770,303 Fair value measured at June 30, 2022 Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) June 30, 2022 Derivative liability $ - $ - $ 577,180 $ 577,180 Total $ - $ - $ 577,180 $ 577,180 The fair value accounting standards define fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is determined based upon assumptions that market participants would use in pricing an asset or liability. Fair value measurements are rated on a three-tier hierarchy as follows: ● Level 1 inputs: Quoted prices (unadjusted) for identical assets or liabilities in active markets; ● Level 2 inputs: Inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly; and ● Level 3 inputs: Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions. There were no transfers between Level 1, 2 or 3 during the nine months ended March 31, 2023. During the nine months ended March 31, 2023 and 2022, the Company recorded gains of $341,913 and $25,139, respectively, from the change in fair value of derivative liability. The following table presents changes in Level 3 liabilities measured at fair value for the period ended March 31, 2023: Derivative Liability Balance – June 30, 2022 $ 577,180 Changes due to issuances 535,036 Change in fair value of derivative liability (341,913) Balance – March 31, 2023 $ 770,303 The balance of the derivative liability at March 31, 2023 and June 30, 2022 was $770,303 and $577,180, respectively.

Note 8 - Subsequent Events

Note 8 - Subsequent Events	9 Months Ended
	Mar. 31, 2023
Notes
Note 8 - Subsequent Events	Note 8 – Subsequent Events On April 24, 2023, the Company sold convertible note bearing 12% interest in the principal amount of $280,000. The note is disbursed in two tranches with a first tranche of $80,000 and second tranche of $200,000. On April 24, 2023, the Company issued 500,000 shares of common stock to a third party for services valued at $5,900 with price at $0.0118 per share. On April 30, 2023, the Company sold convertible note bearing 12% interest in the principal amount of $100,000. The note is disbursed in three tranches with first tranche of $20,000 to be issued upon execution of the note. The second and third tranches of $40,000 each were to be issued on or before June 1, 2023 and July 1, 2023, respectively.

Note 1 - Organization and Sum_2

Note 1 - Organization and Summary of Significant Accounting Policies: Organization (Policies)	9 Months Ended
	Mar. 31, 2023
Policies
Organization	Organization APPlife Digital Solutions Inc. (the “Company”) is a business incubator and portfolio manager that uses digital technology to create and invest in e-commerce and cloud-based solutions. The Company was formed March 5, 2018 in Nevada and has offices in San Francisco, California and Shanghai, China. Our office in San Francisco, California allows us to take advantage of the marketing opportunities available in the United States as well as keeping close proximity to sources of capital whether it is debt or equity. Our offices in Shanghai, China allows us to take advantage of a high concentration of skilled tech coders and developers at lower capital costs than in more developed countries such as the United States or Europe. Rooster Essentials APP SPV, LLC (the “Rooster”), incorporated on April 9, 2019, is a wholly owned subsidiary of the Company. Rooster is a fully customizable men’s ecommerce platform that delivers daily use grooming needs and essential items. B2BCHX SPV LLC (the “B2BCHX”), incorporated on June 5, 2019, is a wholly owned subsidiary of the Company. B2BCHX does an independent background check on mainland Chinese companies for small businesses globally. Office Hop, incorporated on January 28, 2021, is a wholly owned subsidiary of the Company. Office Hop is a global sharing model platform for short term rentals of office and meeting rooms. Users can find an office or conference space for hourly, half-day, full-day, or weekly rental. Hosts can list their spare office or meeting rooms.

Note 1 - Organization and Sum_3

Note 1 - Organization and Summary of Significant Accounting Policies: Going Concern (Policies)	9 Months Ended
	Mar. 31, 2023
Policies
Going Concern	Going Concern The Company has generated losses and negative cash flows from operations since inception. The Company has historically financed its operations from equity financing. The Company anticipates additional equity financings to fund operations in the future. Should management fail to adequately address the issue, the Company may have to reduce its business activities or curtail its operations. There can be no assurance that any additional financings, would be available to the Company on satisfactory terms and conditions if at all. The current pandemic known as COVID-19 as described in Note 5, creates additional uncertainty. The accompanying unaudited condensed consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and classification of liabilities and commitments in the normal course of business. The accompanying unaudited condensed consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classifications of liabilities that might result if the Company is unable to continue as a going concern.

Note 1 - Organization and Sum_4

Note 1 - Organization and Summary of Significant Accounting Policies: Basis of Presentation (Policies)	9 Months Ended
	Mar. 31, 2023
Policies
Basis of Presentation	Basis of Presentation The Company’s unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for the interim financial information and with instructions to Form 10-Q and Article 10 of Regulation S-X. The unaudited condensed consolidated financial statements include the accounts of all subsidiaries in which the Company holds a controlling financial interest as of the financial statement date. All intercompany transactions have been eliminated in consolidation. However, in the opinion of the management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these statements. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended June 30, 2022, as filed with the SEC on October 7, 2022. Operating results for the nine months ended March 31, 2023 are not necessarily indicative of the results that may be expected for any subsequent quarter or for the fiscal year ending June 30, 2023.

Note 1 - Organization and Sum_5

Note 1 - Organization and Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)	9 Months Ended
	Mar. 31, 2023
Policies
Cash and Cash Equivalents	Cash and Cash Equivalents For the purpose of the statement of cash flows, the Company considers cash equivalents to include cash and investments with an original maturity of three months or less.

Note 1 - Organization and Sum_6

Note 1 - Organization and Summary of Significant Accounting Policies: Income Taxes (Policies)	9 Months Ended
	Mar. 31, 2023
Policies
Income Taxes	Income Taxes The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume that the tax position will be examined by taxing authorities. The Company’s policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. The Company had no accrual for interest or penalties as of March 31, 2023. The Company files income tax returns with the Internal Revenue Service (“IRS”) and the state of California.

Note 1 - Organization and Sum_7

Note 1 - Organization and Summary of Significant Accounting Policies: Use of Estimates (Policies)	9 Months Ended
	Mar. 31, 2023
Policies
Use of Estimates	Use of Estimates Generally accepted accounting principles require that the consolidated financial statements include estimates by management in the valuation of certain assets and liabilities. Significant matters requiring the use of estimates and assumptions include, but are not necessarily limited to, fair value of the Company’s stock, stock-based compensation, BCF (Beneficial Conversion Feature) liabilities feature of convertible debt, and valuation allowance relating to the Company’s deferred tax assets. Management uses its historical records and knowledge of its business in making these estimates. Management believes that its estimates and assumptions are reasonable, based on information that is available at the time they are made. Accordingly, actual results could differ from those estimates.

Note 1 - Organization and Sum_8

Note 1 - Organization and Summary of Significant Accounting Policies: Revenue Recognition (Policies)	9 Months Ended
	Mar. 31, 2023
Policies
Revenue Recognition	Revenue Recognition The Company will recognize revenue from the sale of products and services in accordance with ASC 606, “Revenue from Contracts with Customers”,

Note 1 - Organization and Sum_9

Note 1 - Organization and Summary of Significant Accounting Policies: Stock Based Compensation (Policies)	9 Months Ended
	Mar. 31, 2023
Policies
Stock Based Compensation	Stock Based Compensation The Company accounts for share-based compensation in accordance with the fair value recognition provision of FASB ASC 718, Compensation – Stock Compensation (“ASC 718”), prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the financial statements based on the estimated grant date fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505, Equity–based Payments to Non-Employees (“ASC 505”). Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

Note 1 - Organization and Su_10

Note 1 - Organization and Summary of Significant Accounting Policies: Net Loss per Share (Policies)	9 Months Ended
	Mar. 31, 2023
Policies
Net Loss per Share	Net Loss per Share Basic net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period, increased by potentially dilutive common shares (“dilutive securities”) that were outstanding during the period. Dilutive securities include stock options and warrants granted, convertible debt, and convertible preferred stock. Restricted shares issued are not included in the calculation of the weighted-average number of common shares outstanding. There were 30,499,099 and 5,094,959 potentially dilutive securities for the nine months ended March 31, 2023 and year ended June 30, 2022, respectively.

Note 1 - Organization and Su_11

Note 1 - Organization and Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies)	9 Months Ended
	Mar. 31, 2023
Policies
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company follows FASB ASC 820, Fair Value Measurements and Disclosures Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts reported in the Company’s consolidated financial statements for cash, accounts payable and accrued expenses approximate their fair value because of the immediate or short-term nature of these consolidated financial instruments.

Note 1 - Organization and Su_12

Note 1 - Organization and Summary of Significant Accounting Policies: Derivative Liability (Policies)	9 Months Ended
	Mar. 31, 2023
Policies
Derivative Liability	Derivative Liability FASB ASC 815, Derivatives and Hedging requires all derivatives to be recorded on the consolidated balance sheet at fair value. As of March 31, 2023, we used the Black-Scholes-Merton (BSM) model to estimate the fair value of the conversion feature of the convertible note. Key assumptions of the BSM model include the market price of our stock, the conversion price of the debt, applicable volatility rates, risk-free interest rates and the instrument’s remaining term. These assumptions require significant management judgment. In addition, changes in any of these variables during a period can result in material changes in the fair value (and resultant gains or losses) of this derivative instrument.

Note 1 - Organization and Su_13

Note 1 - Organization and Summary of Significant Accounting Policies: Inventories (Policies)	9 Months Ended
	Mar. 31, 2023
Policies
Inventories	Inventories Inventory, consisting of raw materials, work in process and products available for sale, are primarily accounted for using the first-in, first-out method (“FIFO”), and are valued at the lower of cost or net realizable value. This valuation requires management to make judgements based on currently available information, about the likely method of disposition, such as through sales to individual customers and returns to product vendors. As of March 31, 2023, the Company had inventories of approximately $80,041. The Company has no allowance for inventory reserves.

Note 2 - Notes payable to sto_2

Note 2 - Notes payable to stockholders: Schedule of Debt (Tables)	9 Months Ended
	Mar. 31, 2023
Tables/Schedules
Schedule of Debt	Amount Balance of notes payable, net of discount on June 30, 2022 $ 389,319 Amortization of debt discount 315,810 New Issuances 445,000 Embedded Conversion Feature - Debt discount (445,000) Conversion of Notes Payable less Accrued Interest to stock options (360,000) Balance of notes payable, net of discount as of March 31, 2023 $ 345,129

Note 6 - Stockholders' Equity_2

Note 6 - Stockholders' Equity (Deficit): Schedule of Stock Compensation Expense (Tables)	9 Months Ended
	Mar. 31, 2023
Tables/Schedules
Schedule of Stock Compensation Expense	Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended March 31, 2023 March 31, 2022 March 31, 2023 March 31, 2022 Restricted stock awards $ 558,714 $ 427,557 $ 1,431,722 $ 1,262,058 Stock options awards 28,223 64,010 232,324 169,700 Stock compensation expense $ 586,937 $ 491,567 $ 1,664,046 $ 1,431,758

Note 6 - Stockholders' Equity_3

Note 6 - Stockholders' Equity (Deficit): Schedule of Stock Option Activity (Tables)	9 Months Ended
	Mar. 31, 2023
Tables/Schedules
Schedule of Stock Option Activity	Options Weighted Average Exercise Price per Share Weighted Average Remaining Life (Years) Outstanding – June 30, 2022 23,502,035 $ 0.11 2.92 Granted 6,997,064 0.03 4.69 Forfeited - - - Exercised - - - Outstanding – March 31, 2023 30,499,099 $ 0.05 4.25

Note 6 - Stockholders' Equity_4

Note 6 - Stockholders' Equity (Deficit): Schedule of Assumptions Used (Tables)	9 Months Ended
	Mar. 31, 2023
Tables/Schedules
Schedule of Assumptions Used	Nine Months Ended March 31, 2023 Stock price $ 0.02 - 0.03 Exercise price $ 0.02 - 0.34 Expected term (in years) 4.94 – 5.00 Volatility (annual) 195.1 % - 380.5 % Risk-free rate 2.42 % - 4.22%

Note 7 - Derivative Liability_

Note 7 - Derivative Liability: Schedule of valuation methodology (Tables)	9 Months Ended
	Mar. 31, 2023
Tables/Schedules
Schedule of valuation methodology	Nine Months Ended March 31, 2023 Stock price $ 0.02 – 0.05 Exercise price $ 0.02 – 0.03 Contractual term (in years) 0.74 – 2.00 Volatility (annual) 213% - 381% Risk-free rate 3.51% – 4.45%

Note 7 - Derivative Liability_2

Note 7 - Derivative Liability: Fair Value, Liabilities Measured on Recurring Basis (Tables)	9 Months Ended
	Mar. 31, 2023
Tables/Schedules
Fair Value, Liabilities Measured on Recurring Basis	Fair value measured at March 31, 2023 Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) March 31, 2023 Derivative liability $ - $ - $ 770,303 $ 770,303 Total $ - $ - $ 770,303 $ 770,303 Fair value measured at June 30, 2022 Quoted prices in active markets Significant other observable inputs Significant unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) June 30, 2022 Derivative liability $ - $ - $ 577,180 $ 577,180 Total $ - $ - $ 577,180 $ 577,180

Note 7 - Derivative Liability_3

Note 7 - Derivative Liability: Schedule of Derivative Liabilities at Fair Value (Tables)	9 Months Ended
	Mar. 31, 2023
Tables/Schedules
Schedule of Derivative Liabilities at Fair Value	The following table presents changes in Level 3 liabilities measured at fair value for the period ended March 31, 2023: Derivative Liability Balance – June 30, 2022 $ 577,180 Changes due to issuances 535,036 Change in fair value of derivative liability (341,913) Balance – March 31, 2023 $ 770,303

Note 1 - Organization and Su_14

Note 1 - Organization and Summary of Significant Accounting Policies: Net Loss per Share (Details) - shares	9 Months Ended	12 Months Ended
	Mar. 31, 2023	Jun. 30, 2022
Details
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	30,499,099	5,094,959

Note 1 - Organization and Su_15

Note 1 - Organization and Summary of Significant Accounting Policies: Inventories (Details) - USD ($)	Mar. 31, 2023	Jun. 30, 2022
Details
Inventories	$ 80,041	$ 64,200

Note 2 - Notes payable to sto_3

Note 2 - Notes payable to stockholders (Details) - USD ($)	Dec. 21, 2022	Aug. 26, 2022	Jun. 08, 2022	Feb. 04, 2022	Mar. 08, 2021	Feb. 19, 2021	Jan. 12, 2021
January 2021 Note | Investor
Debt Instrument, Interest Rate, Stated Percentage							12%
Debt Instrument, Face Amount							$ 360,000
January 2021 Note | Tranches 1
Debt Instrument, Face Amount						$ 180,000
Embedded Conversion Feature					$ 35,500
January 2021 Note | Tranches 2
Debt Instrument, Face Amount					180,000
Embedded Conversion Feature					$ 7,500
February 2022 Note | Investor
Debt Instrument, Interest Rate, Stated Percentage				12%
Debt Instrument, Face Amount				$ 350,000
February 2022 Note | Tranches 1
Debt Instrument, Face Amount				100,000
February 2022 Note | Tranches 2
Debt Instrument, Face Amount				150,000
February 2022 Note | Tranches 3
Debt Instrument, Face Amount				$ 100,000
June 2022 Note
Debt Instrument, Face Amount			$ 1,108,000
June 2022 Note - 2
Debt Instrument, Face Amount			$ 282,838
August 2022 Note
Debt Instrument, Interest Rate, Stated Percentage		12%
Debt Instrument, Face Amount		$ 325,000
August 2022 Note | Tranches 1
Debt Instrument, Face Amount		125,000
August 2022 Note | Tranches 2
Debt Instrument, Face Amount		$ 100,000
December 2022 Note
Debt Instrument, Interest Rate, Stated Percentage	12%
Debt Instrument, Face Amount	$ 120,000
December 2022 Note | Tranches 1
Debt Instrument, Face Amount	40,000
December 2022 Note | Tranches 2
Debt Instrument, Face Amount	20,000
December 2022 Note | Tranches 3
Debt Instrument, Face Amount	20,000
December 2022 Note | Tranches 4
Debt Instrument, Face Amount	$ 40,000

Note 2 - Notes payable to sto_4

Note 2 - Notes payable to stockholders: Schedule of Debt (Details) - USD ($)	9 Months Ended
	Mar. 31, 2023	Jun. 30, 2022
Details
Notes Payable	$ 345,129	$ 389,319
Amortization of debt discount	315,810
Proceeds from Issuance of Long-Term Debt	445,000
Embedded Conversion Feature - debt discount	(445,000)
Conversion of Notes Payable less Accrued Interest to stock options	$ (360,000)

Note 3 - Related Party Transa_2

Note 3 - Related Party Transactions (Details) - USD ($)	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 21, 2022	Aug. 26, 2022
Proceeds from notes payable to shareholders	$ 445,000	$ 100,000
August 2022 Note
Debt Instrument, Face Amount				$ 325,000
August 2022 Note | Tranches 1
Debt Instrument, Face Amount				125,000
August 2022 Note | Tranches 2
Debt Instrument, Face Amount				$ 100,000
December 2022 Note
Debt Instrument, Face Amount			$ 120,000
December 2022 Note | Tranches 1
Debt Instrument, Face Amount			40,000
December 2022 Note | Tranches 2
Debt Instrument, Face Amount			20,000
December 2022 Note | Tranches 3
Debt Instrument, Face Amount			20,000
December 2022 Note | Tranches 4
Debt Instrument, Face Amount			$ 40,000

Note 6 - Stockholders' Equity_5

Note 6 - Stockholders' Equity (Deficit) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Common Stock, Shares, Outstanding	150,043,635		150,043,635		148,543,635
Common Stock, Shares, Issued	150,043,635		150,043,635		148,543,635
Common stock issued for cash, Value			$ 18,300	$ 520,000
Common stock issued for services, Value	$ 18,300	$ 39,858		144,141
Share-Based Payment Arrangement, Expense	558,714	427,557	1,431,722	1,262,058
notes payable and interest converted into options to purchase common stock, value			$ 1,309,838	$ 436,044
notes payable and interest converted into options to purchase common stock, shares			8,106,723	2,952,548
Stock Options
Common stock issued for services, Value		144,141	$ 18,300	$ 144,141
Expense Related to the Vesting of Stock Options	$ 28,223	$ 64,010	$ 232,324	$ 169,700
Common Stock
Common stock issued for cash, Shares			1,500,000	5,200,000
Common stock issued for cash, Value			$ 1,500	$ 5,200
Common stock issued for services, Shares	1,500,000	1,898,023		3,819,018
Common stock issued for services, Value	$ 1,500	$ 1,898		$ 3,819
Common Stock | Stock Options
Common stock issued for services, Shares		3,819,018	1,500,000	3,819,018

Note 6 - Stockholders' Equity_6

Note 6 - Stockholders' Equity (Deficit): Schedule of Stock Compensation Expense (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Restricted Stock Awards
Stock compensation expense	$ 558,714	$ 427,557	$ 1,431,722	$ 1,262,058
Stock Options
Stock compensation expense	28,223	64,010	232,324	169,700
Stock compensation expense	$ 586,937	$ 491,567	$ 1,664,046	$ 1,431,758

Note 6 - Stockholders' Equity_7

Note 6 - Stockholders' Equity (Deficit): Schedule of Stock Option Activity (Details) - $ / shares	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Details
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	30,499,099		23,502,035
Weighted Average Exericse Price, Balance	$ 0.05		$ 0.11
Weighted Average Remaining Life, outstanding	4 years 3 months	2 years 11 months 1 day
Options granted	6,997,064
Weighted Average Exericse Price, Granted	$ 0.03
Share Based Compensation Arrangement By Share Based Payment Award, Grants in Period, Weighted Average Remaining Contractual Term	4 years 8 months 8 days
Options forfeited	0
Weighted Average Exericse Price, Forfeited	$ 0
Options exercised	0
Weighted Average Exericse Price, Exercised	$ 0

Note 6 - Stockholders' Equity_8

Note 6 - Stockholders' Equity (Deficit): Schedule of Assumptions Used (Details)	9 Months Ended
	Mar. 31, 2023 $ / shares
Minimum
Stock Price	$ 0.02
Exercise Price	$ 0.02
Expect term (in years)	8 months 26 days
Volatility (annual)	213%
Risk-free rate	3.51%
Maximum
Stock Price	$ 0.05
Exercise Price	$ 0.03
Expect term (in years)	2 years
Volatility (annual)	381%
Risk-free rate	4.45%
Stock Options | Minimum
Stock Price	$ 0.02
Exercise Price	$ 0.02
Expect term (in years)	4 years 11 months 8 days
Volatility (annual)	195.10%
Risk-free rate	2.42%
Stock Options | Maximum
Stock Price	$ 0.03
Exercise Price	$ 0.34
Expect term (in years)	5 years
Volatility (annual)	380.50%
Risk-free rate	4.22%

Note 7 - Derivative Liability_4

Note 7 - Derivative Liability: Schedule of valuation methodology (Details)	9 Months Ended
	Mar. 31, 2023 $ / shares
Minimum
Stock Price	$ 0.02
Exercise Price	$ 0.02
Expect term (in years)	8 months 26 days
Volatility (annual)	213%
Risk-free rate	3.51%
Maximum
Stock Price	$ 0.05
Exercise Price	$ 0.03
Expect term (in years)	2 years
Volatility (annual)	381%
Risk-free rate	4.45%

Note 7 - Derivative Liability_5

Note 7 - Derivative Liability: Fair Value, Liabilities Measured on Recurring Basis (Details) - USD ($)	Mar. 31, 2023	Jun. 30, 2022
Fair Value, Inputs, Level 1
Derivative liabilities	$ 0	$ 0
Fair Value, Inputs, Level 2
Derivative liabilities	0	0
Fair Value, Inputs, Level 3
Derivative liabilities	770,303	577,180
Derivative liabilities	$ 770,303	$ 577,180

Note 7 - Derivative Liability (

Note 7 - Derivative Liability (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Details
Change in fair value of derivative liability	$ 91,241	$ 616	$ 341,913	$ 25,139
Derivative liabilities	$ 770,303		$ 770,303		$ 577,180

Note 7 - Derivative Liability_6

Note 7 - Derivative Liability: Schedule of Derivative Liabilities at Fair Value (Details) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022	Jun. 30, 2022
Details
Derivative liabilities	$ 770,303		$ 770,303		$ 577,180
Changes due to issuances			535,036
Change in fair value of derivative liability	$ (91,241)	$ (616)	$ (341,913)	$ (25,139)